Home/Publication/Hahn & Co and KIP Back Plasma-derived Therapies
Hahn & Co and KIP Back Plasma-derived Therapies 

20 Nov 2024

US$ 19.00

Hahn & Co and Korea Investment Partners have agreed to invest 165 billion won (US$118.9 million) in SK Plasma Co Ltd...

Price / article: US$19.00
OR existing subscriber
Related Publications
Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.